6Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction[ J]. N Engl J Med, 2006, 355(3) :251 -259. 被引量：1
8Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population based study[ J]. N Engl J Med, 2006, 355(3):260-269. 被引量：1
9Sandesson JE. Heart failure with a normal ejection fraction [ J ]. Heart, 2007, 93(2):155-158. 被引量：1
10Heart Faliure Society of American : Executive summary : HFSA 2006 comprehensive Heart Failure practice Guideline [ J ]. J Card Fail, 2006, 12(1) :10 -38. 被引量：1
1UlHaq MA, Wong C, Hare DL. Heart failure with preserved ejectionfraction: an insight into its prevalence, predictors, and implications ofearly detection[J]. Rev Cardiovasc Med, 2015, 16(1): 20-27. 被引量：1
2Chang S, Davidson PM, Newton PJ, et al. Composite outcomemeasures in a pragmatic clinical trial of chronic heart failuremanagement: a comparative assessment[J]. Int J Cardiol, 2015, 185:62-68. 被引量：1
3Sayer G, Bhat G. The renin-angiotensin-aldosterone system and heartfailure[J]. Cardiol Clin, 2014, 32(1): 21-32. 被引量：1
4Birner C, Ulucan C, Bratfisch M, et al. Antihypertrophic effects ofcombined inhibition of the renin-angiotensin system (RAS) andneutral endopeptidase (NEP) in progressive, tachycardia-inducedexperimental heart failure[J]. Naunyn Schmiedebergs ArchPharmacol, 2012, 385(11): 1117-1125. 被引量：1
5Tang CH, Chen TH, Wang CC, et al. Renin-angiotensin systemblockade in heart failure patients on long-term haemodialysis inTaiwan[J]. Eur J Heart Fail, 2013, 15(10): 1194-1202. 被引量：1
